Table 1 Demographics and follow-up of case series

Gender

M

F

F

F

F

F

M

M

GA(W)

27^+ 2

31^+ 6

26^+ 6

24^+ 6

25^+ 5

24^+ 3

29^+ 4

29^+ 1

27^+ 1

BW(g)

800

1440

910

690

700

650

1160

1300

855

Antenatal steroid

–

+

–

–

–

–

+

+

38%

Max Milk intake (ml/kg/d)

9

5.5

16.8

5.8

28.5

12.3

6.9

12.3

10.7

Antenatal infection

+

+

+

+

–

–

–

–

50%

Vaginal/CS

V

CS

V

V

V

V

CS

V

CS 25%

Asphyxia at birth

+

+

+

+

+

+

+

–

88%

Res support

nIMV

Hiflow

nIMV

nIMV

nIMV

nIMV

SIMV

Hiflow

hsPDA

+

–

+

+

–

+

–

+

63%

ibuprofen

+

–

+

+

–

+

–

–

50%

Antibiotics used^a

PT + M

PT + M

PT + M

PT + M + F

PT + M

PT + M

PT + M

PT + M + F

WBC(×10^9/l)

24.9

13.2

44.1

29.0

19.5

38.9

6.6

38.9

Neutrophil (%)

54.4

64.9

69.5

49.1

75.9

68.5

34.5

72.1

CRP

< 0.5

75.7

< 0.5

1.2

0.9

35.3

2.1

9.9

Postnatal day of discovering perforation

8

5

8

10

7

10

5

6

8

X-ray normalisation after discovery (day)

10

13

12

7

17

6

7

5

9

Postnatal day of start feeding

31

25

28

40

36

47

26

26

30

Fasting time

23

20

20

30

29

37

21

20

22

Postnatal day of full feed

60

50

68

155

73

149

50

58

64

Postnatal day of discharge

90

53

69

178

105

153

52

59

80